136 related articles for article (PubMed ID: 9219551)
21. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.
Plooy AC; Fichtinger-Schepman AM; Schutte HH; van Dijk M; Lohman PH
Carcinogenesis; 1985 Apr; 6(4):561-6. PubMed ID: 4039227
[TBL] [Abstract][Full Text] [Related]
22. Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients.
Poirier MC; Reed E; Litterst CL; Katz D; Gupta-Burt S
Cancer Res; 1992 Jan; 52(1):149-53. PubMed ID: 1727376
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3.
Lee KB; Parker RJ; Bohr V; Cornelison T; Reed E
Carcinogenesis; 1993 Oct; 14(10):2177-80. PubMed ID: 8222071
[TBL] [Abstract][Full Text] [Related]
24. Effect of DNA conformation on cisplatin adduct formation.
Bubley GJ; Xu J; Kupiec N; Sanders D; Foss F; O'Brien M; Emi Y; Teicher BA; Patierno SR
Biochem Pharmacol; 1996 Mar; 51(5):717-21. PubMed ID: 8615910
[TBL] [Abstract][Full Text] [Related]
25. Increased sensitivity for determination of polycyclic aromatic hydrocarbon-DNA adducts in human DNA samples by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA).
Schoket B; Doty WA; Vincze I; Strickland PT; Ferri GM; Assennato G; Poirier MC
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):349-53. PubMed ID: 8348058
[TBL] [Abstract][Full Text] [Related]
26. The formation and persistence of carboplatin-DNA adducts in rats.
Blommaert FA; Michael C; van Dijk-Knijnenburg HC; Schornagel JH; den Engelse L; Fichtinger-Schepman AM
Cancer Chemother Pharmacol; 1996; 38(3):273-80. PubMed ID: 8646803
[TBL] [Abstract][Full Text] [Related]
27. DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo.
Mello JA; Lippard SJ; Essigmann JM
Biochemistry; 1995 Nov; 34(45):14783-91. PubMed ID: 7578087
[TBL] [Abstract][Full Text] [Related]
28. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair.
Chao CC
Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556
[TBL] [Abstract][Full Text] [Related]
29. Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts.
Malina J; Kasparkova J; Natile G; Brabec V
Chem Biol; 2002 May; 9(5):629-38. PubMed ID: 12031669
[TBL] [Abstract][Full Text] [Related]
30. Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention.
De Flora S; Balansky R; Scatolini L; Di Marco C; Gasparini L; Orlando M; Izzotti A
IARC Sci Publ; 1996; (139):291-301. PubMed ID: 8923039
[TBL] [Abstract][Full Text] [Related]
31. Methyl methanesulfonate adduct formation and repair in the DHFR gene and in mitochondrial DNA in hamster cells.
Pirsel M; Bohr VA
Carcinogenesis; 1993 Oct; 14(10):2105-8. PubMed ID: 8222061
[TBL] [Abstract][Full Text] [Related]
32. Base sequence-specific attack of stilbene estrogen metabolite(s) on the mitochondrial DNA: implications in the induction of instability in the mitochondrial genome in the kidney of Syrian hamsters.
Thomas RD; Roy D
Int J Mol Med; 2001 Apr; 7(4):389-95. PubMed ID: 11254879
[TBL] [Abstract][Full Text] [Related]
33. Use of a monoclonal antibody to detect DNA damage caused by the anticancer drug cis-diamminedichloroplatinum (II) in vivo and in vitro.
Chao CC; Shieh TC; Huang H
FEBS Lett; 1994 Oct; 354(1):103-9. PubMed ID: 7957889
[TBL] [Abstract][Full Text] [Related]
34. Cross-resistance to cisplatin in cells resistant to photofrin-mediated photodynamic therapy.
Moorehead RA; Armstrong SG; Wilson BC; Singh G
Cancer Res; 1994 May; 54(10):2556-9. PubMed ID: 7909492
[TBL] [Abstract][Full Text] [Related]
35. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
Dreij K; Seidel A; Jernström B
Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
[TBL] [Abstract][Full Text] [Related]
36. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
37. Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells.
Johnson SW; Swiggard PA; Handel LM; Brennan JM; Godwin AK; Ozols RF; Hamilton TC
Cancer Res; 1994 Nov; 54(22):5911-6. PubMed ID: 7954422
[TBL] [Abstract][Full Text] [Related]
38. Influence of treatment temperature on the genotoxic effects of cisplatin in CHO cells: cytotoxicity, mutagenicity and induction of lesions in DNA.
Plooy AC; van Dijk M; Berends F; Lohman PH
Mutat Res; 1985 Aug; 151(1):129-36. PubMed ID: 4040605
[TBL] [Abstract][Full Text] [Related]
39. HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts.
Hoffmann JS; Locker D; Villani G; Leng M
J Mol Biol; 1997 Jul; 270(4):539-43. PubMed ID: 9245584
[TBL] [Abstract][Full Text] [Related]
40. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair.
Chao CC
Mol Pharmacol; 1994 Jun; 45(6):1137-44. PubMed ID: 8022407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
